Related Experiment Video
Updated: May 8, 2026
07:20
Studies on the Anti-Inflammatory Effect of Xiaoyao Pills in The Treatment of Postmenopausal Osteoporosis in Mice
Published on: August 23, 2024
Osteoporosis genetics: year 2011 in review
David Karasik1, Miri Cohen-Zinder
1Faculty of Medicine in the Galilee, Bar-Ilan University , Safed, Israel .
Bonekey Reports
|August 17, 2013
Summary
Genetic studies in 2011 identified new genes linked to osteoporosis and fractures, but the exact genetic causes remain elusive. Advanced methods like whole-genome sequencing are now crucial for uncovering osteoporosis
Area of Science:
- Genetics
- Osteoporosis Research
- Bone Biology
Background:
- Osteoporotic fractures are a growing global health concern due to population aging.
- Current genetic research aims to identify genes and mutations contributing to osteoporosis and fractures.
- Existing genome-wide association studies (GWAS) have explained only a small portion of osteoporosis heritability.
Purpose of the Study:
- To review human genetic studies published in 2011 that identify genomic regions, genes, and mutations associated with osteoporosis and fractures.
- To highlight recent findings and emerging strategies in osteoporosis genetic research.
Main Methods:
- Review of human genetic studies focusing on osteoporosis and fractures from 2011.
- Analysis of genome-wide association studies (GWAS) for bone mineral density (BMD) and related traits.
- Discussion of targeted sequencing and functional genomics approaches.
Main Results:
- GWAS identified WNT16 and MEF2C as genes associated with BMD.
- New single-nucleotide polymorphisms in NOGGIN and SMAD6 were linked to fracture non-union.
- Candidate genes like RAP1A (bone metabolism and lactation) and ACTN3 (bone and muscle pleiotropy) were suggested.
Conclusions:
- Despite progress, the genetic basis of osteoporosis and fractures is not fully understood.
- Targeted sequencing and advanced genomics strategies are essential for discovering causal variants.
- Future research is shifting towards whole-genome sequencing, epigenetics, and functional genomics.
Related Concept Videos
01:29Bone Disorders
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
01:31Osteoclasts in Bone Remodeling
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
01:40Bone Remodeling
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
01:17Hormones and Bone Tissue
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
01:25Role of Vitamins in Maintaining Bone Health
The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
01:29Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...